Miriam K Franchini

Title: The Innovations of Miriam K. Franchini

Introduction

Miriam K. Franchini is a notable inventor based in Allentown, NJ (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. Her work focuses on innovative compositions and methods that have the potential to improve patient care and treatment outcomes.

Latest Patents

Franchini's latest patents include groundbreaking developments in pharmaceutical compositions. One of her notable inventions is related to C-21 modified epothilone derivatives. This patent provides stable compositions that can be easily prepared for intravenous administration. It also discloses a process for formulating these derivatives for both oral and parenteral administration. Another significant patent is for carvedilol methanesulfonate, which relates to compositions containing this compound and methods for treating hypertension, congestive heart failure, and angina.

Career Highlights

Throughout her career, Miriam K. Franchini has worked with prominent companies in the pharmaceutical industry. She has been associated with Bristol-Myers Squibb Company and SmithKline Beecham Corporation. Her experience in these organizations has contributed to her expertise and innovative capabilities in drug development.

Collaborations

Franchini has collaborated with esteemed colleagues, including Krishnaswamy Srinivas Raghavan and Ubrani V. Venkataram. These collaborations have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Miriam K. Franchini's contributions to pharmaceutical innovations demonstrate her commitment to advancing medical science. Her patents reflect her dedication to improving treatment options for various health conditions.